Prenatal history and physical examination
Diagnosis of pregnancy
is usually the first sign of conception. Other symptoms include breast fullness and tenderness, skin changes, nausea, vomiting, urinary frequency, and fatigue.
Urine pregnancy tests may be positive within days of the first missed menstrual period. Serum beta human chorionic gonadotropin (HCG) is accurate up to a few days after implantation.
Fetal heart tones
can be detected as early as 11-12 weeks from the last menstrual period (LMP) by Doppler. The normal fetal heart rate is 120-160 beats per minute.
("quickening") are first felt by the patient at 17-19 weeks.
will visualize a gestational sac at 5- 6 weeks and a fetal pole with movement and cardiac activity by 7-8 weeks. Ultrasound can estimate fetal age accurately if completed before 24 weeks.
Estimated date of confinement.
The mean duration of pregnancy is 40 weeks from the LMP. Estimated date of confinement (EDC) can be calculated by Nägele's rule: Add 7 days to the first day of the LMP, then subtract 3 months.
Recent oral contraceptive usage often causes postpill amenorrhea, and may cause erroneous pregnancy dating.
Gynecologic and obstetric history
1. Gravidity is the total number of pregnancies. Parity is expressed as the number of term
pregnancies, preterm pregnancies, abortions, and live births.
2. The character and length of previous labors, type of delivery, complications, infant status, and birth weight are recorded.
3. Assess prior cesarean sections and determine type of C-section (low transverse or classical), and determine reason it was performed.
Medical and surgical history
and prior hospitalizations are documented.
and allergies are recorded.
of medical illnesses, hereditary illness, or multiple gestation is sought.
Cigarettes, alcohol, or illicit drug use.
Review of systems.
Abdominal pain, constipation, headaches, vaginal bleeding, dysuria or urinary frequency, or hemorrhoids.
Basic Prenatal Medical History
Current Pregnancy History
- Endocrine disorder
- Cardiovascular disease
- Congenital anomalies
- Rheumatic Fever
- Thromboembolic disease
- Kidney disease
- Urinary tract infections
- Neurologic or muscular disorders
- Seizure disorder
- Arteriovenous malformation
- Gastrointestinal disease
- Gall bladder disease
- Inflammatory bowel disease
- Autoimmune disorder
- Systemic lupus
- Rheumatoid arthritis
- History of blood transfusion
- Pulmonary disease
- Breast disorders Infectious diseases
- Gynecologic history
- Abnormal PAP smear
- Genital tract disease or
- Surgical procedures
- Substance abuse
- Illicit drugs
Illicit drug use
Exposure to radiation
Nausea, vomiting, weight loss
Exposure to toxic substances
Initial Prenatal Assessment of past Obstetrical History
Date of delivery
Gestational age at delivery
Location of delivery
Sex of child
Mode of delivery
Type of anesthesia
Length of labor
Outcome (miscarriage, stillbirth, ectopic, etc.)
Details (eg, type of cesarean section scar, forceps, etc.)
Complications (maternal, fetal child)
1. Weight, funduscopic examination, thyroid, breast, lungs, and heart are examined.
2. An extremity and neurologic exam are completed, and the presence of a cesarean section scar is sought.
3. Pelvic examination
a. Pap smear and culture for gonorrhea are completed routinely. Chlamydia culture is
completed in high-risk patients.
b. Estimation of gestational age by uterine size
(1) The nongravid uterus is 3 x 4 x 7 cm. The uterus begins to change in size at 5-6
(2) Gestational age is estimated by uterine size: 8 weeks = 2 x normal size; 10 weeks = 3 x normal; 12 weeks = 4 x normal.
(3) At 12 weeks the fundus becomes palpable at the symphysis pubis.
(4) At 16 weeks, the uterus is midway between the symphysis pubis and the umbilicus.
(5) At 20 weeks, the uterus is at the umbilicus. After 20 weeks, there is a correlation
between the number of weeks of gestation and the number of centimeters from the pubic symphysis to the top of the fundus.
(6) Uterine size that exceeds the gestational dating by 3 or more weeks suggests
multiple gestation, molar pregnancy, or (most commonly) an inaccurate date for LMP. Ultrasonography will confirm inaccurate dating or intrauterine growth failure.
c. Adnexa are palpated for masses.
Initial visit laboratory testing
. A standard panel of laboratory tests should be obtained on every pregnant woman at the first prenatal visit. Chlamydia screening is recommended for all pregnant women.
Initial Prenatal Laboratory Examination
Blood type and antibody screen
Hematocrit or hemoglobin
Rubella status (immune or nonimmune)
Urinary infection screen
Hepatitis B surface antigen
HIV counseling and testing
Human immunodeficiency virus
HIV testing is recommended for all pregnant women.
Retesting in the third trimester (around 36 weeks of gestation) is recommended for women at high risk for acquiring HIV infection.
At-risk women should receive additional tests:
Gonorrhea, tuberculosis and red cell indices to screen for thalassemia (eg, MCV <80), hemoglobin electrophoresis to detect hemoglobinopathies (eg, sickle cell, thalassemias)
Hexosaminidase A for Tay Sachs screening (serum test in nonpregnant and leukocyte assay in pregnant individuals), DNA analysis for Canavan's disease, cystic fibrosis carrier testing, serum phenylalanine level, toxoplasmosis screen, and Hepatitis C antibodies.
Testing for sexually transmitted diseases (eg, HIV, syphilis, hepatitis B surface antigen,
chlamydia, gonorrhea) should be repeated in the third trimester in any woman at high risk for acquiring these infections; all women under age 25 years should be retested for Chlamydia trachomatis late in pregnancy.
CBC, AB blood typing and Rh factor, antibody screen, rubella, VDRL/RPR, hepatitis B surface Ag.
Pap smear, urine pregnancy test, urinalysis and urine culture. Cervical culture for gonorrhea and chlamydia.
Tuberculosis skin testing, HIV counseling/testing.
Initial patient education
Frequency of prenatal visits, recommendations for nutrition, weight gain, exercise, rest, and sexual activity, routine pregnancy monitoring (eg, weight, urine dipstick, blood pressure, uterine growth, fetal activity and heart rate), listeria precautions, toxoplasmosis precautions (eg, hand washing, eating habits, cat care) should be discussed.
Abstinence from alcohol, cigarettes, illicit drugs should be assessed. Information on the safety of commonly used nonprescription drugs, signs and symptoms to be reported should be discussed, as appropriate for gestational age (eg, vaginal bleeding,ruptured membranes, contractions, decreased fetal activity).
Headache and backache.
Aspirin is contraindicated.
Nausea and vomiting.
First-trimester morning sickness may be relieved by eating frequent, small meals, getting out of bed slowly after eating a few crackers, and by avoiding spicy or greasy foods.
A high-fiber diet with psyllium (Metamucil), increased fluid intake, and regular exercise should be advised.
Nutrition, vitamins, and weight gain
All pregnant women should be encouraged to eat a well-balanced diet. Folic acid is recommended in the preconceptional and early prenatal period to prevent neural tube defects (NTDs). A standard prenatal multivitamin satisfies the requirements of most pregnant women.
Nutritional recommendations for pregnant women are based upon the prepregnancy body mass index (BMI). A weight gain of 12.5 to 18 kg (28 to 40 lb) for underweight women (BMI<19.8), 7 to 11.5 kg (15 to 25 lb) for overweight women (BMI $26), and 11.5 to 16 kg (25 to 35 lb) for women of average weight (BMI 19.8 to 26.0) is recommended.
Clinical assessment at first trimester prenatal visits
Routine examination at each subsequent visit consists of measurement of blood pressure and weight, measurement of the uterine fundus to assess fetal growth, auscultation of fetal heart tones, and determination of fetal presentation and activity. The urine is typically screened for protein and glucose at each visit.
At 9 to 12 weeks the fetal heart usually can be heard by of gestation using a Doppler instrument. Transvaginal ultrasound can determine fetal viability as early as 5.5 to 6.5 weeks.
Clinical assessment at second trimester visits:-
First detection of fetal movement (quickening)
should occur at around 17 weeks in a
multigravida and at 19 weeks in a primigravida.
should be documented at each visit after 17 weeks.
Vaginal bleeding or symptoms of preterm labor
should be sought.
Fetal heart rate
is documented at each visit.
Maternal serum testing at 15-16 weeks:
Triple screen ("-fetoprotein, human chorionic gonadotropin [hCG], estriol). In women under age 35 years, screening for fetal Down syndrome is accomplished with a triple screen.
Levels of hCG are higher in Down syndrome and levels of unconjugated estriol are lower in Down syndrome.
If levels are abnormal, an ultrasound examination is performed and genetic amniocentesis is offered.
At 15-18 weeks, genetic amniocentesis should be offered to patients >35 years old, and it should be offered if a birth defect has occurred in the mother, father, or in previous offspring.
Screening ultrasound. Ultrasound measurement of crown-rump length at 7 to 14 weeks is the most accurate technique for estimation of gestational age; it is accurate within three to five days.
At 24-28 weeks, a one-hour Glucola (blood glucose measurement 1 hour after 50-gm oral glucose) is obtained to screen for gestational diabetes. Those with a particular risk (eg, previous gestational diabetes or fetal macrosomia), require earlier testing. If the 1 hour test result is greater than 140 mg/dL, a 3-hour glucose tolerance test is necessary.
Second trimester education. Discomforts include backache, round ligament pain, constipation, and indigestion.
Clinical assessment at third trimester visits:-
Fetal movement is documented. Vaginal bleeding or symptoms of preterm labor should be sought. Preeclampsia symptoms (blurred vision, headache, rapid weight gain, edema) are sought.
Fetal heart rate is documented at each visit.
At 26-30 weeks, repeat hemoglobin and hematocrit are obtained to determine the need for iron supplementation.
At 28-30 weeks, an antibody screen is obtained in Rh-negative women, and D immune globulin (RhoGAM) is administered if negative.
At 36 weeks, repeat serologic testing for syphilis is recommended for high risk groups.
Sexually transmitted disease. Testing for sexually transmitted diseases (eg, HIV, syphilis, hepatitis B surface antigen, chlamydia, gonorrhea) should be repeated in the third trimester in any woman at high risk for acquiring these infections; all women under age 25 years should be retested for Chlamydia trachomatis late in pregnancy.
Screening for group B streptococcus colonization at 35-37 weeks. All pregnant women should be screened for group B beta-hemolytic streptococcus (GBS) colonization with swabs of both the lower vagina and rectum at 35 to 37 weeks of gestation. The only patients who are excluded from screening are those with GBS bacteriuria earlier in the current pregnancy or those who gave birth to a previous infant with invasive GBS disease. These latter patients are not included in the screening recommendation because they should receive intrapartum antibiotic prophylaxis regardless of the colonization status.
Influenza immunization is recommended for women in the second and third trimesters and for high-risk women prior to influenza season regardless of stage of pregnancy.
Third trimester education
Signs of labor. The patient should call physician when rupture of membranes or contractions have occurred every 5 minutes for one hour.
Danger signs. Preterm labor, rupture of membranes, bleeding, edema, signs of preeclampsia.
Common discomforts. Cramps, edema, frequent urination.
36 weeks, a cervical exam may be completed. Fetal position should be assessed by palpation.